Member Info for bighammer

NICE is a world wide respected accreditation , if they reccommend a product for the uk NHS then that goes a long way with other countries including the US . If you were a private health care company would you not want to offer this test to your customers? , if you have private care then you would pay quite willingly for the test for your child , i would even pay if i was in the nhs to save any possible grandchild of mine from losing their hearing .

Been at work all day did i miss something ????????. Not quite what i was expecting i must admit , especially with the closing sp down 15% , looks like the mms have had afield day today . Was the news already priced in , is it oversold , not really sure now but the stroke test is nt priced in , FDA application is nt priced in and sales are nt priced in so for me all is not lost by a long way . Good luck to those who have or are trading GDR and making money and i am still sure i will , eventually lol.

Stephen , read a lot worse than that on my tobacco packets and still smoking lol.

A few things stood out for me , NICE dont really look at long term savings more at short term expences but trust managers and accountants will . They feel more than 1 machine will be needed in case their is more than 1 child need the test thus more expense and the ethnicity of the child needs more information which could be a plus or a minus depending where in the world we sell it . The big problem for me is that the report is not in the plain yes or no english which most of us ( including me ) were hoping for or can easily understand.

Morning System , i dont think it is the big tick we were expecting as the report is not in what we consider as yes or no but trying to read into it and taking their concerns into account on a unique test then it is as good as we can expect imo . They cant jump up and down claiming it to be the best thing since sliced bread as they are dealing with childrens lives , but for me it is a big tick but more information is still needed to be gathered .

I must admit i agree Durham , just feel we wont have to wait that long. as has been said companies going into takeover mode want to see productivity and a sales stream but still with plenty of legs left , so sales from AIHL and stroke test in a number of countries , preferably US and then who knows .

Rodney , we are thinking on the same lines , and i honestly feel tne final offer price will be over £3 , why ?, because if and i think when we have approval for AIHL and stroke test where needed that would equate to over £200m per annum gross plus IP so there will be a few pharmas would be more than happy to have all that in their portfolio of companies and be able to develop the ever growing genomic testing with the information we have at our disposal which is why i am going to hold 25% of my holding until it happens.

MIKODX, its not looking to great on the market in general so some investors might just start looking to other markets and chances they would not normally venture into to make some profit , the medium and long term do look like they might be going in our favour for a change .

Starrs , you have pretty much bang on for me , possibly not rising quite that high afterwards . I think we will see a 40% spike and settle about15-20%up as most feel it is a given , but the big rises will come when we go for a FDA application and then stroke test launch , then we will see some big rises. As regards financing which we will need in the next month or two , the company will know if they are going to get any grants , have an idea of how much they can predictably raise in the next 6 months so then work out how much they will need to raise to see them through the next 12 months . I and some others were thinking in the £5-8m , but this may not be the case it could be as low as £3-5m and with the previous said news due the discount may be as little as 15-20% and nowhere near the scaremongering 40% quoted this week by some . The sp is going to be like a coiled spring over the next 4-8 weeks but if everything goes to plan in 6 months time minimum the sp will be well north of double what it is now as we will have stroke launch , full NICE acc for AIHL and timescale possibilty of FDA approval as it will take 150 calendar days from application and EVEN NICE fastrack for stroke test . OOPS FORGOT , sales for AIHL starting to come in from Europe and almost definately all over the world .

Cant argue with that Roger , but if we get sales news within the next couple of months from Europe etc your target may be hit a little bit earlier .

Not sure if i am reading too much into it but it seems they are dealing with regional trusts and not individual trusts now which not only will it make it easier but also quicker ?.

I think those that sold in the mid 40s will now see it as agood buy in with 30 percent profit banked .

I did not even think about gegional adoption , even better , work time so enjoy what happens today .

It will be interesting what media interest we get AFTER NICE approval , this is a unique test to stop some newborn babies from going deaf, have the stories already been filmed ???.

£5-8m?.

MIKODX , wasnt that what they were reccomending before the public consultation ?. and it is possible when they release full news at the end of the month they could already have those answers if contact with the hospitals already using it ? . Not saying they will but a possibility .

Stephen , i am hoping we go for a fund raise after NICE accreditation as the sp will be high enough to be able to get the amount of funds needed with a small discount with the pre empt of stroke test launch and FDA application as the carrot to increase their investment .
System , as for other countries needing their own approval i dont honestly know but what i do know is that the FDA will look very favourably at NICE accreditation in deciding how they will go so i am working on the premise is , if its good enough for the FDA then it will be good enough for the others .
As regards takeover offers i cant see them coming in until we have steady sales of AIHL and more than likely stroke test which could be 12 months away but i am expecting it to be WELL NORTH of £1 , why ?. AIHL predicted gross sales for UK , US , and Europe is £70m ish not including the rest of the world , then add in the stroke test , make your own thought about that , that is per annum . Then add in the value of their IP for genomic testing which is the buzz word at the minute . Sticking my neck out here i feel that we will have a few pharmas will look to bid when the time is right but any final offer will be over £300m , which if you equate that to sales when both tests are in full sales mode could equate to just 18 months of sales . NOW i am not saying that what i have written is backed up by hard and fast facts or nailed on information and those targets will be hit , these are just my own thoughts of where i feel it could realistically get .

Waited about 2 years to break even which has just happened might hang around for a while longer to make some good profits now .

Aim it gets a little complicated i think when you are trading it , as long as you are in profit , happy days.

Retirement plans underway then Roger . I think you are underestimating any potential takeover offer as DD will have been carried out by pharmas who know what it is really worth to them , would £500m be a bargain ?????.